BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 14711693)

  • 21. [Resistance to quinolones and beta-lactams in Salmonella enterica due to mutations in topoisomerase-encoding genes, altered cell permeability and expression of an active efflux system].
    Miró E; Vergés C; García I; Mirelis B; Navarro F; Coll P; Prats G; Martínez-Martínez L
    Enferm Infecc Microbiol Clin; 2004 Apr; 22(4):204-11. PubMed ID: 15056435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibiotics susceptibility of quinolones against Salmonella spp. strains isolated and molecularly sequenced for gyrA gene.
    Macías-Farrera GP; de Oca Jiménez RM; Varela-Guerrero J; Tenorio-Borroto E; Rivera-Ramírez F; Monroy-Salazar HG; Yong-Angel G
    Microb Pathog; 2018 Jan; 114():286-290. PubMed ID: 29208542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. gyrA and parC Mutations and associated quinolone resistance in Vibrio anguillarum serotype O2b strains isolated from farmed Atlantic cod (Gadus morhua) in Norway.
    Colquhoun DJ; Aarflot L; Melvold CF
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2597-9. PubMed ID: 17502408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of mechanisms involved in reduced susceptibility to ciprofloxacin in Salmonella enterica serotypes Typhi and Paratyphi A isolates from travellers to Southeast Asia.
    Hassing RJ; Menezes GA; van Pelt W; Petit PL; van Genderen PJ; Goessens WH
    Int J Antimicrob Agents; 2011 Mar; 37(3):240-3. PubMed ID: 21227657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bartonella bacilliformis, endemic pathogen of the Andean region, is intrinsically resistant to quinolones.
    del Valle LJ; Flores L; Vargas M; García-de-la-Guarda R; Quispe RL; Ibañez ZB; Alvarado D; Ramírez P; Ruiz J
    Int J Infect Dis; 2010 Jun; 14(6):e506-10. PubMed ID: 19969497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patterns of quinolone susceptibility in Campylobacter jejuni associated with different gyrA mutations.
    McIver C; Hogan T; White P; Tapsall J
    Pathology; 2004 Apr; 36(2):166-9. PubMed ID: 15203753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of mutations in the gyrA gene and class I integron from quinolone-resistant Salmonella enterica serovar Choleraesuis isolates in Taiwan.
    Huang TM; Chang YF; Chang CF
    Vet Microbiol; 2004 Jun; 100(3-4):247-54. PubMed ID: 15145503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CRISPR/Cas9/sgRNA-mediated targeted gene modification confirms the cause-effect relationship between gyrA mutation and quinolone resistance in Escherichia coli.
    Qiu H; Gong J; Butaye P; Lu G; Huang K; Zhu G; Zhang J; Hathcock T; Cheng D; Wang C
    FEMS Microbiol Lett; 2018 Jul; 365(13):. PubMed ID: 29767711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in physiology and virulence during the selection of resistant Yersinia ruckeri mutants under subinhibitory cefotaxime concentrations.
    García-Torrico AI; Guijarro JA; Cascales D; Méndez J
    J Fish Dis; 2019 Dec; 42(12):1687-1696. PubMed ID: 31617230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. First Streptococcus agalactiae isolates highly resistant to quinolones, with point mutations in gyrA and parC.
    Kawamura Y; Fujiwara H; Mishima N; Tanaka Y; Tanimoto A; Ikawa S; Itoh Y; Ezaki T
    Antimicrob Agents Chemother; 2003 Nov; 47(11):3605-9. PubMed ID: 14576126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of Yersinia ruckeri strains isolated from trout farms in northwest Germany.
    Huang Y; Jung A; Schäfer WJ; Mock D; Brenner Michael G; Runge M; Schwarz S; Steinhagen D
    Dis Aquat Organ; 2015 Oct; 116(3):243-9. PubMed ID: 26503779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of Quinolone-Resistant Determinants in Tribe
    Wimalasena SHMP; Pathirana HNKS; Shin GW; De Silva BCJ; Hossain S; Heo GJ
    Microb Drug Resist; 2019 May; 25(4):611-618. PubMed ID: 30427748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutations in gyrA and parC QRDRs are not relevant for quinolone resistance in epidemiological unrelated Stenotrophomonas maltophilia clinical isolates.
    Ribera A; Doménech-Sanchez A; Ruiz J; Benedi VJ; Jimenez de Anta MT; Vila J
    Microb Drug Resist; 2002; 8(4):245-51. PubMed ID: 12523620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential expression of virulence genes and role of gyrA mutations in quinolone resistant and susceptible strains of Salmonella Weltevreden and Newport isolated from seafood.
    Deekshit VK; Kumar BK; Rai P; Karunasagar I; Karunasagar I
    J Appl Microbiol; 2015 Oct; 119(4):970-80. PubMed ID: 26249136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction of nalidixic acid and ciprofloxacin with wild type and mutated quinolone-resistance-determining region of DNA gyrase A.
    Vashist J; Vishvanath ; Kapoor R; Kapil A; Yennamalli R; Subbarao N; Rajeswari MR
    Indian J Biochem Biophys; 2009 Apr; 46(2):147-53. PubMed ID: 19517991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutations responsible for reduced susceptibility to 4-quinolones in clinical isolates of multi-resistant Salmonella typhi in India.
    Brown JC; Shanahan PM; Jesudason MV; Thomson CJ; Amyes SG
    J Antimicrob Chemother; 1996 May; 37(5):891-900. PubMed ID: 8737139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of gyrA Mutations in Nalidixic Acid-Resistant Strains of Salmonella Enteritidis Isolated from Humans, Food, Chickens, and the Farm Environment in Brazil.
    Campioni F; Souza RA; Martins VV; Stehling EG; Bergamini AMM; Falcão JP
    Microb Drug Resist; 2017 Jun; 23(4):421-428. PubMed ID: 27559761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of plasmid-mediated quinolone resistance determinants among Escherichia coli isolated from food animals in Korea.
    Tamang MD; Nam HM; Chae MH; Kim SR; Gurung M; Jang GC; Jung SC; Lim SK
    Foodborne Pathog Dis; 2012 Dec; 9(12):1057-63. PubMed ID: 23186547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High prevalence of nalidixic acid resistant, ciprofloxacin susceptible phenotype among clinical isolates of Escherichia coli and other Enterobacteriaceae.
    Ruiz J; Gómez J; Navia MM; Ribera A; Sierra JM; Marco F; Mensa J; Vila J
    Diagn Microbiol Infect Dis; 2002 Apr; 42(4):257-61. PubMed ID: 12007443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced fluoroquinolone susceptibility in Salmonella enterica serotypes in travelers returning from Southeast Asia.
    Hakanen A; Kotilainen P; Huovinen P; Helenius H; Siitonen A
    Emerg Infect Dis; 2001; 7(6):996-1003. PubMed ID: 11747728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.